| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Axcella Health Inc. | Director | Stock Option (Right to Buy) | 40,000 | 19 May 2022 | Direct | ||
| Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | 16 Jun 2023 | Direct | |
| Prometheus Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | 16 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323015762-hendrix-martin-2023-06-16 | Prometheus Biosciences, Inc. | 16 Jun 2023 | 3 | $0 | 4 | Director | 16 Jun 2023, 16:00 |
| /report/000120919123031180-hendrix-martin-2023-05-19 | Prometheus Biosciences, Inc. | 19 May 2023 | 1 | $0 | 4 | Director | 19 May 2023, 17:41 |
| /report/000110465922063986-hendrix-martin-2022-05-19 | Axcella Health Inc. | 19 May 2022 | 1 | $0 | 4 | Director | 23 May 2022, 19:40 |
| /report/000110465922063984-hendrix-martin-2022-05-19 | Axcella Health Inc. | 19 May 2022 | 0 | $0 | 3 | Director | 23 May 2022, 19:39 |
| /report/000120919122031174-hendrix-martin-2022-05-19 | Prometheus Biosciences, Inc. | 19 May 2022 | 1 | $0 | 4 | Director | 20 May 2022, 19:22 |